Our management team has had many successes, especially in connection with starting, building and investing in technology related companies.
View Management Team
View Board of Directors
Be The First to Receive Breaking News
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells
Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry
Cancer Fact: 27% of global cancer deaths occur in China.